The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
Open accessAbstract
Angiotensin II (AII)- and Arg8-vasopressin (AVP)-regulated gene expression in vascular cells has been reported to contribute to vascular homeostasis and hypertrophy. In this report, AVP-induced expression of plasminogen activator inhibitor (PAI)-2 mRNA in rat microvessel endothelial (RME) cells was identified using differential mRNA display. Further characterization of vasoactive peptide effects on PAI expression revealed that AII stimulated a 44.8 +/- 25.2-fold and a 12.4 +/- 3.2-fold increase in PAI-2 mRNA in RME cells and rat aortic smooth muscle cells (RASMC), respectively. AII also stimulated a 10- and 48-fold increase in PAI-1 mRNA in RME cells and RASMC, respectively. These AII effects were inhibited by either Sar1, Ile8-angiotensin or the AT1 antagonist DuP 735, but were not significantly altered in the presence of the AT2 antagonist PD123319. AII stimulation of RASMC and RME cells also significantly increased both PAI-1 protein and PAI activity released to the culture medium. Inhibition of protein kinase C completely blocked PMA-stimulated induction of PAI-2 mRNA in both cell types and inhibited the AII-stimulated increase in RASMC by 98.6 +/- 2.8%. In contrast, protein kinase C inhibition only partially decreased the AII-stimulated PAI-2 expression in RME cells by 68.8 +/- 11.1%, suggesting that a protein kinase C-independent mechanism contributes to a 6.9 +/- 1.5-fold AII induction of PAI-2 expression in endothelial cells. AII and PMA also stimulated protein tyrosine phosphorylation in RME cells, and the tyrosine kinase inhibitor genistein partially blocked their induction of PAI-2 mRNA. These findings suggest that AII may regulate plasminogen activation in the vasculature by inducing both PAI-1 and PAI-2 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
Liang, P., & Pardee, A. B. (1992) · Science · doi:10.1126/science.1354393 · Cited by 4,984
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., & Loriolle, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98476-0 · Cited by 2,456
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,853
Molecular basis of human hypertension: Role of angiotensinogen
Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850
The plasminogen activator/plasmin system.
Vassalli, J. D., Sappino, A. P., & Belin, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115405 · Cited by 1,164
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Schunkert, H., Hense, H.-W., Holmer, S. R., Stender, M., Perz, S., Keil, U., Lorell, B. H., & Riegger, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302302 · Cited by 740
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Naftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
Linkage of the Angiotensinogen Gene to Essential Hypertension
Caulfield, M., Lavender, P., Farrall, M., Munroe, P., Lawson, M., Turner, P., & Clark, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302301 · Cited by 575
Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., Nogami, A., Murumo, F., & Hiroe, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116579 · Cited by 573
Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.
Berk, B. C., Vekshtein, V, Gordon, H. M., & Tsuda, T. (1989) · Hypertension · doi:10.1161/01.hyp.13.4.305 · Cited by 556
Griendling, K. K., Rittenhouse, S. E., Brock, T. A., Ekstein, L. S., Gimbrone, M. A., & Alexander, R. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38468-5 · Cited by 489
Itoh, H., Mukoyama, M., Pratt, R. E., Gibbons, G. H., & Dzau, V. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116454 · Cited by 469
King, G. L., Goodman, A. D., Buzney, S., Moses, A., & Kahn, C. R. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111764 · Cited by 437
Self-citationLaborda, J. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3998 · Cited by 427
Raynolds, M. V., Bristow, M. R., Bush, E. W., Abraham, W. T., Lowes, B. D., Zisman, L. S., Taft, C. S., & Perryman, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92061-w · Cited by 413
Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993) · Circulation · doi:10.1161/01.cir.87.6.1969 · Cited by 400
Angiotensin II Induces c-fos mRNA in Aortic Smooth Muscle
Taubman, M. B., Berk, B. C., Izumo, S., Tsuda, T., Alexander, R. W., & Nadal-Ginard, B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31290-5 · Cited by 396
Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., De Mol, M., Mulligan, R. C., & Collen, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116893 · Cited by 388
Marre, M., Bernadet, P., Gallois, Y., Savagner, F., Guyene, T.-T., Hallab, M., Cambien, F., Passa, P., & Alhenc-Gelas, F. (1994) · Diabetes · doi:10.2337/diab.43.3.384 · Cited by 366
Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.
Imai, T., Hirata, Y., Emori, T., Yanagisawa, M., Masaki, T., & Marumo, F. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.753 · Cited by 359
Plasminogen Activator Inhibitors - A Review
Kruithof, E. K. O. (2017) · Enzyme · doi:10.1159/000469153 · Cited by 292
Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene
Erickson, L. A., Fici, G. J., Lund, J. E., Boyle, T. P., Polites, H. G., & Marotti, K. R. (1990) · Nature · doi:10.1038/346074a0 · Cited by 267
Stimulation of endothelin-1 gene expression by insulin in endothelial cells.
Oliver, F. J., de la Rubia, G., Feener, E. P., Lee, M. E., Loeken, M. R., Shiba, T., Quertermous, T., & King, G. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54489-6 · Cited by 227
Self-citationSimonson, M. S., & Herman, W. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98357-2 · Cited by 223
Doria, A., Warram, J. H., & Krolewski, A. S. (1994) · Diabetes · doi:10.2337/diab.43.5.690 · Cited by 191
Influence of the angiotensin system on endothelial and smooth muscle cell migration.
Bell, L. B., & Madri, J. A. (1990) · Europe PMC (PubMed Central) · Cited by 181
ACE Inhibitors — A Cornerstone of the Treatment of Heart Failure
Braunwald, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250508 · Cited by 155
Taubman, M. B., Marmur, J. D., Rosenfield, C.-L., Guha, A., Nichtberger, S., & Nemerson, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116234 · Cited by 151
Jaiswal, N., Diz, D. I., Chappell, M. C., et al. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii49 · Cited by 132
Reilly, C., & McFall, R. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92836-x · Cited by 128
Aiello, L. P., Robinson, G. S., Lin, Y. W., Nishio, Y., & King, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6231 · Cited by 96
Self-citationSchunkert, H., Ingelfinger, J. R., Hirsch, A. T., Tang, S., Litwin, S. E., Talsness, C. E., & Dzau, V. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116020 · Cited by 92
Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy.
Morishita, R., Higaki, J., Miyazaki, M., & Ogihara, T. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii62 · Cited by 89
Marre, M., Bernadet, P., Gallois, Y., Savagner, F., Guyene, T. T., Hallab, M., Cambien, F., Passa, P., & Alhenc‐Gelas, F. (1994) · Diabetes · doi:10.2337/diabetes.43.3.384 · Cited by 86
Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display
Nishio, Y., Aiello, L. P., & King, G. L. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.1.8299882 · Cited by 85
Self-citationHACHIYA, H. L., Takayama, S., White, M. F., & King, G. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45586-x · Cited by 84
Self-citationIsolation and characterization of the rat plasminogen activator inhibitor-1 gene.
Bruzdzinski, C. J., Riordan-Johnson, M., Nordby, E. C., Suter, S. M., & GELEHRTER, T. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39942-9 · Cited by 74
Ullian, M. E., & Linas, S. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40215-9 · Cited by 66
Cousin, E., Medcalf, R. L., Bergonzelli, G. E., & Kruithof, E. K. O. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3881 · Cited by 55
Hu, K. Q., Backer, J., Sahagian, G. A., Feener, E. P., & King, G. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77428-0 · Cited by 32
Self-citationKo, Y. D., Stiebler, H., Nickenig, G., et al. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.6.496 · Cited by 30
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Minireview: Adiposity, Inflammation, and Atherogenesis
Lyon, C. J., Law, R. E., & Hsueh, W. A. (2003) · Endocrinology · doi:10.1210/en.2003-0285 · Cited by 761
Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies
Patel, S., Rauf, A., Khan, H., & Abu-Izneid, T. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.091 · Cited by 626
Metadata
- Authors
- Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 1353-1362
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2134107449
- Cited by
- 255
- References
- 47
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.